FDA approves blood typing tests

Jan 14, 2008

The U.S. Food and Drug Administration has licensed 14 new tests for determining a person's blood type.

"These 14 new tests will provide blood establishments and transfusion services with additional choices to help assure safe, well-matched transfusions," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "The tests offer a broader diversity of reliable blood-typing tests and will help protect against product shortages."

Knowing the blood types for blood donors and patients is critical since patients might experience serious life-threatening reactions from mismatched transfused blood.

The OLYMPUS PK System Blood Group and Phenotyping Reagents use monoclonal antibodies to test for the A, B, O, and Rh factors, as well as for other factors that signify a rarer blood type, the FDA said.

The tests are manufactured by DIAGAST of Loos Cedex, France.

Copyright 2008 by United Press International

Explore further: Rapivab approved to help treat flu

add to favorites email to friend print save as pdf

Related Stories

Can stress management help save honeybees?

Nov 24, 2014

Honeybee populations are clearly under stress—from the parasitic Varroa mite, insecticides, and a host of other factors—but it's been difficult to pinpoint any one of them as the root cause of devast ...

Social robots helping children with diabetes

Nov 14, 2014

Social robots are helping diabetic children accept the nature of their condition and become more confident about their futures, scientists have announced following a four-and-a-half year research study.

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

13 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.